Desmoteplase-mediated plasminogen activation and clot lysis are inhibited by the lysine analogue tranexamic acid

Blood Coagul Fibrinolysis. 2008 Jun;19(4):322-4. doi: 10.1097/MBC.0b013e3282f54568.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antifibrinolytic Agents / pharmacology*
  • Drug Interactions
  • Fibrinolysis / drug effects*
  • Fibrinolysis / physiology
  • Fibrinolytic Agents / adverse effects
  • Hemorrhage / chemically induced
  • Hemorrhage / drug therapy*
  • Humans
  • In Vitro Techniques
  • Plasminogen / drug effects*
  • Plasminogen / physiology
  • Plasminogen Activators / adverse effects
  • Tranexamic Acid / pharmacology*

Substances

  • Antifibrinolytic Agents
  • Fibrinolytic Agents
  • salivary plasminogen activator alpha 1, Desmodus rotundus
  • Tranexamic Acid
  • Plasminogen
  • Plasminogen Activators